Scientific symposia and training courses for SAPA-GP members across drug discovery, development, and R&D leadership.
PPS provides scientific symposia and training courses for our members.
The program spans three tracks: the Philadelphia Pharmaceutical Scientific Symposium, the Pharma R&D 360 Training Course, and the Pharma R&D Executive Forum.
Our flagship Philadelphia Pharmaceutical Scientific Symposium convenes experts from academia and industry. Here is our most recent symposium.
2019 Philadelphia Pharmaceutical Scientific Symposium — exploring the digital revolution in BioPharma R&D, from computational drug design to AI in drug discovery, with speakers from academia and industry.
| 8:00–8:30 | Networking and registration |
| 8:30–9:15 | Computational drug design in the post-AI era: basic principles and case studies — Dr. Guosheng Wu |
| 9:15–10:00 | Artificial intelligence and machine learning in pharmaceutical R&D — Dr. Andy Liaw |
| 10:00–10:15 | Coffee break |
| 10:15–11:00 | The impact of AI in drug discovery — Dr. Qingsong Zhu |
| 11:00–11:45 | AI-based digital pathology — Mr. Casey Laris |
| 12:00–13:00 | Lunch |
| 13:00–13:45 | Translational human data to advance drug discovery: challenges and opportunities — Dr. Guna Rajagopal |
| 13:45–14:30 | Digitally-enabled patient-centric clinical trials: current state and future opportunities — Dr. Matthew Moyer |
| 14:30–15:00 | Networking and close |
Propose a topic or sponsor a future symposium.
